制药公司Hikma:将继续与美国政府在贸易政策上进行建设性沟通。确保美国国内可负担药品的稳定供应是我们共同的目标。承诺到2030年在美国制造和研发领域再投资10亿美元。
制药公司Hikma:将继续与美国政府在贸易政策上进行建设性沟通。确保美国国内可负担药品的稳定供应是我们共同的目标。承诺到2030年在美国制造和研发领域再投资10亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.